Skip to main content
ADBIOTECH Co.,Ltd. logo

ADBIOTECH Co.,Ltd. — Investor Relations & Filings

Ticker · 179530 ISIN · KR7179530001 KO Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2024-04-25 Capital/Financing Update
Country KR South Korea
Listing KO 179530

About ADBIOTECH Co.,Ltd.

http://www.adbiotech.com

ADBIOTECH Co., Ltd. is a biotechnology company specializing in the development and commercialization of immune antibodies. The company's core competency is IgY (Immunoglobulin in Yolk) technology, which utilizes antibodies derived from eggs to create alternatives to conventional vaccines and antibiotics. Its product portfolio targets the livestock, aquaculture, and human health sectors, with applications for disease prevention and treatment in animals like salmon and shrimp, as well as human-focused developments for conditions related to Helicobacter pylori and cholesterol. The company manages the entire value chain from research and development to production and sales. ADBIOTECH is also expanding its technological capabilities into VHH (nanobody) technology, with a strategic focus on the global companion animal market.

Recent filings

Filing Released Lang Actions
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) by Adbiotech. It details the terms of the bond, including interest rates, conversion prices, put/call options, and the specific investors involved. This type of filing is a standard regulatory disclosure for capital raising activities in the Korean market, which falls under the 'Capital/Financing Update' category.
2024-04-25 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 1,000 characters) notifying the public about an upcoming Investor Relations (IR) event (a corporate presentation). It provides the date, time, location, and purpose of the meeting. According to the 'Menu vs Meal' rule, since this is an announcement of an event/presentation rather than the presentation slides themselves, and it does not fit into specific categories like 10-K or IR, it is classified as a Regulatory Filing (RNS) as it serves as a formal notice to the exchange.
2024-04-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details changes in share ownership by the major shareholder and special related parties, including reasons such as stock purchases, sales, and changes in special relationship status. This type of filing is a standard regulatory disclosure for significant ownership changes, which falls under the 'Major Shareholding Notification' category.
2024-04-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director appointments, and remuneration limits. This matches the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it reports the official outcomes of shareholder votes at an AGM.
2024-03-28 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to company executives and employees, including the number of shares, exercise price, and vesting conditions. Since this is a specific regulatory disclosure regarding capital structure and equity-based compensation that does not fit into the other specific categories like 'DIRS' (which is for individual insider trades) or 'SHA' (which is for general share issuance), it is classified as a Regulatory Filing (RNS).
2024-03-28 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2023 (Jan 1, 2023 - Dec 31, 2023) for the company 'ADBIOTECH Co., Ltd.'. It contains detailed information about the company's overview, history, capital structure, and business operations. In the context of South Korean corporate filings, the '사업보고서' is the equivalent of the US 10-K annual report, as it is the comprehensive annual disclosure document submitted to the Financial Supervisory Service (FSS). FY 2023
2024-03-20 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.